Re-Engineering Microbial Metabolism for Superior Yields and Novel Bioproducts. Aspergillus niger is one of the most versatile industrial hosts, capable of producing a vast array of organic acids, enzymes, and specialized metabolites. However, natural metabolic pathways are often not optimized for the extreme fluxes required in commercial biomanufacturing. CD Biosynsis offers professional Aspergillus niger Pathway Optimization Services, providing a comprehensive suite of metabolic engineering solutions. By utilizing advanced genomic tools—including CRISPR-Cas9 RNP systems—we identify and eliminate metabolic bottlenecks and redirect carbon flux toward target molecules.
Get a Technical QuoteOur pathway optimization platform combines computational modeling with precision genome editing to enhance the production efficiency of diverse industrial chemicals and proteins. We focus on transforming A. niger into a high-performance cell factory tailored to your specific bioproduction needs.
| Service Tier | Technical Focus | Primary Application | Industrial/Research Value |
|---|---|---|---|
| Precursor Supply Enhancement | Acetyl-CoA & NADPH flux tuning | Organic acids & Lipids | Resolves foundational bottlenecks in synthesis |
| Byproduct Pathway Shunting | Targeted gene knockout/repression | High-purity fermentations | Minimizes carbon loss & simplifies purification |
| Heterologous Pathway Design | Synthetic gene cluster integration | Novel flavors, fragrances & Drugs | Enables production of non-native compounds |
| Feedback Inhibition Relief | Enzyme engineering & Site mutation | High-titer manufacturing | Maintains production at high concentrations |
| Non-Food Substrate Utilization | Bio-conversion of lignocellulose | Circular economy & Waste-to-value | Lowers raw material costs via agricultural waste |
1. Metabolic Flux Analysis
2. Pathway Design
3. Precision Engineering
4. Bioprocess Scaling
Quantitative evaluation of the host’s metabolic network using Genome-Scale Models (GEMs) to identify limiting nodes and wasteful shunts.
Technical project feasibility study and Mutual NDA signing.
Bioinformatic design of synthetic circuits and selection of high-efficiency enzymes from diverse biological sources to bypass natural bottlenecks.
Simulation of carbon redirection to ensure optimal growth-production balance.
Execution of precision knockouts, knock-ins, and promoter swaps using optimized RNP-based CRISPR toolkits in Aspergillus niger.
High-throughput screening of engineered libraries in micro-bioreactors for yield verification.
Optimization of fermentation parameters (pH, temperature, DO) to validate pathway performance at pilot scale.
Final delivery of optimized industrial strains and comprehensive characterization dossiers.
We benchmark our metabolic rewiring against landmark research to maximize industrial yields.
Eliminating bottlenecks in organic acid synthesis is critical. Technical benchmarks demonstrated the engineering of a synthetic phosphoketolase pathway in A. niger to supplement cytosolic Acetyl-CoA. By converting pentose phosphates directly into Acetyl-CoA, researchers bypassed limiting steps of standard glycolysis, enabling a significant increase in citric acid production.
(Reference: J. Fungi, 2023)
The circular bio-economy requires strains that utilize non-traditional feedstocks. Projects utilizing A. niger successfully achieved the bioconversion of ferulic acid from pineapple waste into vanillic acid and vanillin. Through enzymatic optimization and fermentation refinement, researchers transformed residues into high-value bio-based fragrances.
(Reference: Chemistry Central Journal, 2020)
Modern bio-refineries demand platform chemicals like succinic acid. Utilizing a "scarless" RNP-based CRISPR-Cas9 system, technical teams precisely engineered A. niger by knocking out competitive shunts. Redirecting carbon flow toward the reductive TCA cycle resulted in highly efficient production strains, showcasing RNP efficacy for diversifying A. niger product portfolios.
(Reference: Biotechnology for Biofuels, 2020)
Ready to re-engineer your industrial host for maximum bioproduction yield?
Contact Us1. How do you identify which metabolic nodes to optimize?
We utilize Genome-Scale Metabolic Models (GEMs) and 13C-metabolic flux analysis to computationally predict which nodes in the metabolism are limiting the production of your target molecule.
2. Can you optimize a pathway for a non-native, novel molecule?
Yes. We have extensive experience in heterologous pathway reconstruction. We source enzymes from plants, bacteria, or other fungi and integrate them into the Aspergillus niger genome for novel production.
3. What is the advantage of using RNP systems for optimization?
RNP systems do not require Cas9 gene integration. This results in "cleaner" strains with no long-term off-target risks, making the regulatory approval process for the final industrial strain much smoother.
4. Does pathway optimization negatively affect the fungal growth rate?
While some modifications can impose a load, we focus on balancing growth and production. Strategies like inducible repression (CRISPRi) allow the strain to grow robustly before switching to the production phase.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.